DeCaria CM - Search Results

1

Specificity of neuropsychological impairment in obsessive-compulsive disorder: a comparison with social phobic and normal control subjects.

Cohen LJ, Hollander E, DeCaria CM, Stein DJ, Simeon D, Liebowitz MR, Aronowitz BR. Cohen LJ, et al. Among authors: decaria cm. J Neuropsychiatry Clin Neurosci. 1996 Winter;8(1):82-5. doi: 10.1176/jnp.8.1.82. J Neuropsychiatry Clin Neurosci. 1996. PMID: 8845706 Clinical Trial.

2

A pilot follow-up study of childhood soft signs and the development of adult psychopathology.

Hollander E, DeCaria CM, Aronowitz B, Klein DF, Liebowitz MR, Shaffer D. Hollander E, et al. Among authors: decaria cm. J Neuropsychiatry Clin Neurosci. 1991 Spring;3(2):186-9. doi: 10.1176/jnp.3.2.186. J Neuropsychiatry Clin Neurosci. 1991. PMID: 1821234

3

Obsessive compulsive disorder, depression, and fluoxetine.

Hollander E, Mullen L, DeCaria CM, Skodol A, Schneier FR, Liebowitz MR, Klein DF. Hollander E, et al. Among authors: decaria cm. J Clin Psychiatry. 1991 Oct;52(10):418-22. J Clin Psychiatry. 1991. PMID: 1938978 Clinical Trial.

4

Conceptual and methodological issues in studies of obsessive-compulsive and Tourette's disorders.

Hollander E, Liebowitz MR, DeCaria CM. Hollander E, et al. Among authors: decaria cm. Psychiatr Dev. 1989 Winter;7(4):267-96. Psychiatr Dev. 1989. PMID: 2577300 Review.

5

Quantitative electroencephalographic subtyping of obsessive-compulsive disorder.

Prichep LS, Mas F, Hollander E, Liebowitz M, John ER, Almas M, DeCaria CM, Levine RH. Prichep LS, et al. Among authors: decaria cm. Psychiatry Res. 1993 Apr;50(1):25-32. doi: 10.1016/0925-4927(93)90021-9. Psychiatry Res. 1993. PMID: 8511221

6

A pilot study of the neuropsychology of obsessive-compulsive disorder and Parkinson's disease: basal ganglia disorders.

Hollander E, Cohen L, Richards M, Mullen L, DeCaria C, Stern Y. Hollander E, et al. J Neuropsychiatry Clin Neurosci. 1993 Winter;5(1):104-7. doi: 10.1176/jnp.5.1.104. J Neuropsychiatry Clin Neurosci. 1993. PMID: 8428130

7

Induction of depersonalization by the serotonin agonist meta-chlorophenylpiperazine.

Simeon D, Hollander E, Stein DJ, DeCaria C, Cohen LJ, Saoud JB, Islam N, Hwang M. Simeon D, et al. Psychiatry Res. 1995 Sep 29;58(2):161-4. doi: 10.1016/0165-1781(95)02538-8. Psychiatry Res. 1995. PMID: 8570768 Clinical Trial.

8

Seasonal effects in prolactin response to m-chlorophenylpiperazine challenge in obsessive-compulsive disorder.

Grossman R, Cohen L, Rosen J, DeCaria C, Hollander E. Grossman R, et al. Biol Psychiatry. 1996 Jun 1;39(11):982-5. doi: 10.1016/0006-3223(95)00658-3. Biol Psychiatry. 1996. PMID: 9162213 Clinical Trial. No abstract available.

9

Serotonergic function in social phobia: comparison to normal control and obsessive-compulsive disorder subjects.

Hollander E, Kwon J, Weiller F, Cohen L, Stein DJ, DeCaria C, Liebowitz M, Simeon D. Hollander E, et al. Psychiatry Res. 1998 Jul 13;79(3):213-7. doi: 10.1016/s0165-1781(98)00041-9. Psychiatry Res. 1998. PMID: 9704868 Clinical Trial.

10

Reliability and validity of the pathological gambling adaptation of the Yale-Brown Obsessive-Compulsive Scale (PG-YBOCS).

Pallanti S, DeCaria CM, Grant JE, Urpe M, Hollander E. Pallanti S, et al. Among authors: decaria cm. J Gambl Stud. 2005 Winter;21(4):431-43. doi: 10.1007/s10899-005-5557-3. J Gambl Stud. 2005. PMID: 16311876

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

51 results

Search Page

Filters